Reintroduction of treatment with lamotrigine in combination with valproate after an initial allergic skin reaction;Réintroduction de la lamotrigine en association au valproate après une réaction cutanée allergique initiale

Revue Neurologique

Volumn 162, Issue 11, 2006, Pages 1122-1124

  Gelisse P ^a,b   Crespel, A ^a  

^a Unité Médico Chirurgicale de l'Épilepsie   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

Absence epilepsy; Lamotrigine; Rash; Rechallenge

Indexed keywords

LAMOTRIGINE; VALPROIC ACID;

ABSENCE; ADULT; ALLERGIC REACTION; ARTICLE; CASE REPORT; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG RECHALLENGE; HUMAN; INCIDENCE; RISK; SKIN ALLERGY; TITRIMETRY; TREATMENT RESPONSE;

EID: 33750722415     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(06)75125-6     Document Type: Article

References (12)

1. BIRABEN A, ALLAIN H, SCARABIN JM, SCHUCK S, EDAN G. (2000). Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology, 55: 1758.
2. BRODIE MJ, YUEN AW. (1997). Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res, 26: 423-432.
3. CRESPEL A, GENTON P, BERRAMDANE M et al. (2005). Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology, 65: 762-764.
4. GELISSE P, GENTON P, KUATE C, PESENTI A, BALDY-MOULINIER M, CRESPEL A. (2004). Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Epilepsia, 45: 1282-1286.
5. GENTON P, GELISSE P, THOMAS P, DRAVET CH. (2000). Do carbamazepine aggravate juvenile idiopathic epilepsy. Neurology, 55: 1106-1109.
6. GENTON P, GELISSE P, CRESPEL A. (2006). Lack of efficacy and potential aggravation of myoclonus with lamotrigine in Unverricht-Lundborg disease. Epilepsia, in press.
7. GUBERMAN AH, BESAG FMC, BRODIE MJ et al. (1999). Lamotrigine-Associated Rash: Risk/Benefit Considerations in Adults and Children. Epilepsia, 40: 985-991.
8. e édition). Montrouge : John Libbey Eurotext, pp. 315-336.
9. P-CODREA TIGARAN, S, SIDENIUS P, DAM M. (2005). Lamotrigine-induced rash - worth a rechallenge. Acta Neurol Scand, 111: 191-194.
10. PISANI F, RICHENS A. (2002). In: Levy RH, Mattson RH, Meldrum BS, Perucca E eds. Antiepileptic drugs (fifth edition). Philadelphia: Lippincott Williams & Wilkins, pp. 408-416.
11. SEINO M, FUJITANI B. (2002). Zonisamide: Clinical efficacy and use in Epilepsy. In: Levy RH, Mattson RH, Meldrum BS, Perucca E eds. Antiepileptic drugs (fifth edition). Philadelphia: Lippincott Williams & Wilkins, pp 885-891.
12. TAVERNOR SJ, WONG ICK, NEWTON R, BROWN SW. (1995). Rechallenge with lamotrigine after initial rash. Seizure, 4: 67-71.